Vir Biotechnology (VIR) PT Lowered to $13 at BofA Securities
Tweet
Share
E-mailGet Alerts VIR Hot Sheet
Price: $11.63 +6.31%
Rating Summary:
10 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Rating Summary:
10 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Join SI Premium – FREE
BofA Securities analyst Alex Stranahan lowered the price target on Vir Biotechnology (NASDAQ: VIR) to $13.00 (from $14.00) while maintaining a Buy rating.
You May Also Be Interested In
- Designer Brands (DBI) PT Lowered to $6 at UBS
- Kepler Cheuvreux Upgrades Entain PLC (ENT:LN) (GMVHF) to Buy
- Kazia Therapeutics (KZIA) PT Raised to $40 at BTIG
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
